BioAtla, Inc.BCABNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-20.4%
5Y CAGR+38.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-20.4%/yr
vs +28.8%/yr prior
5Y CAGR
+38.4%/yr
Recent deceleration
Acceleration
-49.2pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
5.1x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $53.84M | -35.9% |
| 2024 | $84.02M | -34.6% |
| 2023 | $128.47M | +20.1% |
| 2022 | $106.94M | +10.6% |
| 2021 | $96.69M | +812.6% |
| 2020 | $10.60M | +40.3% |
| 2019 | $7.55M | -80.6% |
| 2018 | $38.86M | - |